Liu L, Jiang C, He H, Li Y, Wu Z
Beijing Neurosurgical Institute, Tiantan Hospital, Capital Medical University, Beijing, China.
Interv Neuroradiol. 2010 Mar;16(1):47-57. doi: 10.1177/159101991001600106. Epub 2010 Mar 25.
The advent of Onyx has provided a new method for neurointerventional therapists to treat brain AVMs. Although some retrospective studies have reported complications for AVM embolization with Onyx, periprocedural bleeding complications with Onyx embolization have not yet been described in detail. The aim of this retrospective study was to analyze the factors of Onyx-related bleeding complications and to find a way to avoid and manage these complications.From January 2003, patients with AVMs recruited in our institution started to be treated by Onyx embolization. From January 2007 to July 2009, 143 consecutive interventions were performed in 126 patients using flow-independent microcatheters and Onyx as embolic agents. Seven patients encountered bleeding complications (5.4% per patients and 4.7% per procedures) during or after the endovascular procedures. Among them, five bleeding episodes occurred during procedures, the other two after procedures. Details of the seven patients' clinical presentations, imaging presentations, speculative reasons and management of these complications were recorded. Follow-up data, including postoperative course, clinical symptoms and duration of follow-up were documented. The five active bleedings discovered in procedures were managed in time, and the patients recovered without any new neurological symptoms compared with preoperation. However, of the two bleeding episodes that occurred after interventional procedures, one was detected half an hour later: the patient was remained comatose two months later after resection of right occipital hematoma; the other who encountered intraventricular and midbrain hemorrhage was treated conservatively and suffered Parinaud syndrome and hemianesthesia.
Periprocedural bleeding of AVMs embolization is considered a severe and devastating complication. The clinical course and prognosis of bleeding mostly depends on prompt detection and management. Interventional embolization is an effective method to manage bleeding during procedures, and the detection of risk factors and imaging signs of bleeding is extremely important.
Onyx的出现为神经介入治疗师治疗脑动静脉畸形(AVM)提供了一种新方法。尽管一些回顾性研究报告了使用Onyx进行AVM栓塞的并发症,但Onyx栓塞围手术期出血并发症尚未得到详细描述。这项回顾性研究的目的是分析与Onyx相关的出血并发症因素,并找到避免和处理这些并发症的方法。自2003年1月起,我院招募的AVM患者开始采用Onyx栓塞治疗。2007年1月至2009年7月,对126例患者连续进行了143次介入治疗,使用血流无关型微导管和Onyx作为栓塞剂。7例患者在血管内操作期间或之后出现出血并发症(每位患者发生率为5.4%,每次操作发生率为4.7%)。其中,5次出血事件发生在操作过程中,另外2次发生在操作后。记录了这7例患者的临床表现细节、影像学表现、推测原因及并发症处理情况。记录了随访数据,包括术后病程、临床症状及随访时间。操作过程中发现的5次活动性出血均得到及时处理,与术前相比,患者恢复良好,未出现任何新的神经症状。然而,在介入操作后发生的2次出血事件中,1次在半小时后被发现:患者在切除右枕叶血肿两个月后仍昏迷;另1例发生脑室内及中脑出血,接受保守治疗,出现帕里诺德综合征和偏身感觉障碍。
AVM栓塞围手术期出血被认为是一种严重且具有破坏性的并发症。出血的临床病程及预后主要取决于及时发现和处理。介入栓塞是处理操作过程中出血的有效方法,识别出血的危险因素及影像学征象极为重要。